Anthony Junsung Choi

Anthony Choi practices at Columbia University Irving Medical Center in New York, New York.

Anthony Choi's NPI, 1033505631, was assigned on April 9, 2015. Anthony Choi graduated from Weill Cornell Medicine in 2015. Anthony Choi holds New York license 286307.

Anthony Choi's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Anthony Choi's primary practice is Columbia University Irving Medical Center in New York, New York. Anthony Choi is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Anthony Choi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anthony Choi practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Anthony Choi's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Anthony Choi is board certified in gastroenterology by the American Board of Internal Medicine. Anthony Choi is licensed in New York.

Dmand AI lists cirrhosis, colonoscopy, fatty liver, gastrointestinal bleeding, gastrointestinal inflammation, liver disease and upper GI endoscopy among the conditions Anthony Choi treats.

CMS data shows 164 Medicare services from Anthony Choi across 5 procedure codes in 2024, for 98 Medicare patients. Medicare paid $20,685 for them.

CMS counts 98 Medicare patients who saw Anthony Choi in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anthony Choi's median patient age at 63, with 46% women.

In 2024, Anthony Choi wrote 174 Medicare Part D claims for 44 patients. 66% of them were for generic drugs. CMS names the drug for 97 of them, across 5 drugs with 11 or more claims each, at $108,660 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Anthony Choi for performance year 2024, reported through an alternative payment model (APM). Anthony Choi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Anthony Choi, published from 2011 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Carcinoma, Hepatocellular and Liver Neoplasms. Anthony Choi has published most often in Sensors (Basel). Anthony Choi's most frequent co-authors are Amy M. Tyberg, MD, Preston J. Atteberry, MD and Robert Brown, MD.

CMS Open Payments shows 40 general payments to Anthony Choi from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 63% of the total. Intercept Pharmaceuticals, Inc. paid the most, $800.

Anthony Choi graduated from Weill Cornell Medicine in 2015.

Anthony Choi is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.